Reilly Financial Advisors’s Immunogen Inc IMGN Stock Holding History

Reilly Financial Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2K	Hold	300	–	–	﹤0.01%	1024
2021 Q3	$2K	Hold	300	–	–	﹤0.01%	875
2021 Q2	$2K	Hold	300	–	–	﹤0.01%	936
2021 Q1	$2K	Hold	300	–	–	﹤0.01%	959
2020 Q4	$2K	Hold	300	–	–	﹤0.01%	827
2020 Q3	$1K	Hold	300	–	–	﹤0.01%	822
2020 Q2	$1K	Hold	300	–	–	﹤0.01%	878
2020 Q1	$1K	Sell	300 -15	-5%	-$66	﹤0.01%	863
2019 Q4	$2K	Hold	315	–	–	﹤0.01%	826
2019 Q3	$1K	Hold	315	–	–	﹤0.01%	880
2019 Q2	$1K	Hold	315	–	–	﹤0.01%	924
2019 Q1	$1K	Hold	315	–	–	﹤0.01%	945
2018 Q4	$2K	Hold	315	–	–	﹤0.01%	875
2018 Q3	$3K	Buy	315 +15	+5%	+$144	﹤0.01%	921
2018 Q2	$3K	Buy	+300	New	+$3.16K	﹤0.01%	902
2017 Q1	–	Sell	-300	Closed	-$1K	–	967
2016 Q4	$1K	Sell	300 -160	-35%	-$321	﹤0.01%	813
2016 Q3	$1K	Hold	460	–	–	﹤0.01%	811
2016 Q2	$1K	Hold	460	–	–	﹤0.01%	779
2016 Q1	$4K	Hold	460	–	–	﹤0.01%	974
2015 Q4	$6K	Buy	460 +360	+360%	+$4.43K	﹤0.01%	902
2015 Q3	$1K	Hold	100	–	–	﹤0.01%	1224
2015 Q2	$1K	Hold	100	–	–	﹤0.01%	1299
2015 Q1	$1K	Buy	+100	New	+$724	﹤0.01%	1245

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Reilly Financial Advisors's IMGN Position: Q4 2021 in Review

Reilly Financial Advisors held its Immunogen Inc (IMGN) position steady in Q4 2021 at 300 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Reilly Financial Advisors first reported a position in IMGN in Q1 2015 and has held it in 23 quarters since. The position peaked at $6K in Q4 2015. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

Reilly Financial Advisors held 300 shares of Immunogen Inc worth $2K as of Q4 2021.
Reilly Financial Advisors left its Immunogen Inc share count unchanged in Q4 2021.
Immunogen Inc made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1024 holding.
Reilly Financial Advisors first reported a position in Immunogen Inc in Q1 2015 and has held it in 23 quarters since.
Reilly Financial Advisors's Immunogen Inc position peaked at $6K in Q4 2015.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.